BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18244953)

  • 1. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses.
    Gauvreau GM; Boulet LP; Cockcroft DW; Baatjes A; Cote J; Deschesnes F; Davis B; Strinich T; Howie K; Duong M; Watson RM; Renzi PM; O'Byrne PM
    Am J Respir Crit Care Med; 2008 May; 177(9):952-8. PubMed ID: 18244953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPI ASM8 reduces eosinophil progenitors in sputum after allergen challenge.
    Imaoka H; Campbell H; Babirad I; Watson RM; Mistry M; Sehmi R; Gauvreau GM
    Clin Exp Allergy; 2011 Dec; 41(12):1740-6. PubMed ID: 21762225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response effects of TPI ASM8 in asthmatics after allergen.
    Gauvreau GM; Pageau R; Séguin R; Carballo D; Gauthier J; D'Anjou H; Campbell H; Watson R; Mistry M; Parry-Billings M; Killian K; Renzi PM
    Allergy; 2011 Sep; 66(9):1242-8. PubMed ID: 21605124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
    Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge.
    Inman MD; Watson RM; Rerecich T; Gauvreau GM; Lutsky BN; Stryszak P; O'Byrne PM
    Am J Respir Crit Care Med; 2001 Aug; 164(4):569-74. PubMed ID: 11520717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma.
    Gauvreau GM; Boulet LP; Postma DS; Kawayama T; Watson RM; Duong M; Deschesnes F; De Monchy JG; O'Byrne PM
    J Allergy Clin Immunol; 2005 Aug; 116(2):285-91. PubMed ID: 16083781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma.
    Gauvreau GM; Boulet LP; Cockcroft DW; Fitzgerald JM; Carlsten C; Davis BE; Deschesnes F; Duong M; Durn BL; Howie KJ; Hui L; Kasaian MT; Killian KJ; Strinich TX; Watson RM; Y N; Zhou S; Raible D; O'Byrne PM
    Am J Respir Crit Care Med; 2011 Apr; 183(8):1007-14. PubMed ID: 21057005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantageous toxicity profile of inhaled antisense oligonucleotides following chronic dosing in non-human primates.
    Guimond A; Viau E; Aubé P; Renzi PM; Paquet L; Ferrari N
    Pulm Pharmacol Ther; 2008 Dec; 21(6):845-54. PubMed ID: 18761414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.
    Boot JD; de Haas S; Tarasevych S; Roy C; Wang L; Amin D; Cohen J; Sterk PJ; Miller B; Paccaly A; Burggraaf J; Cohen AF; Diamant Z
    Am J Respir Crit Care Med; 2007 Mar; 175(5):450-7. PubMed ID: 17170385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses.
    Gauvreau GM; Hessel EM; Boulet LP; Coffman RL; O'Byrne PM
    Am J Respir Crit Care Med; 2006 Jul; 174(1):15-20. PubMed ID: 16574937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.
    Krug N; Hohlfeld JM; Kirsten AM; Kornmann O; Beeh KM; Kappeler D; Korn S; Ignatenko S; Timmer W; Rogon C; Zeitvogel J; Zhang N; Bille J; Homburg U; Turowska A; Bachert C; Werfel T; Buhl R; Renz J; Garn H; Renz H
    N Engl J Med; 2015 May; 372(21):1987-95. PubMed ID: 25981191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological modulation of allergen-induced asthma.
    Ma LL; O'Byrne PM
    Inflammopharmacology; 2013 Apr; 21(2):113-24. PubMed ID: 23096484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
    Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic worsening of airway inflammation during low-dose allergen exposure in asthma: protection by inhaled steroids.
    de Kluijver J; Evertse CE; Schrumpf JA; van der Veen H; Zwinderman AH; Hiemstra PS; Rabe KF; Sterk PJ
    Am J Respir Crit Care Med; 2002 Aug; 166(3):294-300. PubMed ID: 12153960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.
    Gauvreau GM; FitzGerald JM; Boulet LP; Watson RM; Hui L; Villineuve H; Scime TX; Schlatman AR; Obminski C; Kum J; Boehme S; Ly TW; Bacon KB; O'Byrne PM
    Clin Exp Allergy; 2018 Apr; 48(4):445-451. PubMed ID: 29423947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation.
    Gauvreau GM; Watson RM; O'Byrne PM
    Am J Respir Crit Care Med; 1999 Jan; 159(1):31-6. PubMed ID: 9872814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.
    Louw C; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbroker D; Bardin PG
    Respiration; 2007; 74(4):411-7. PubMed ID: 16954654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial.
    Neighbour H; Boulet LP; Lemiere C; Sehmi R; Leigh R; Sousa AR; Martin J; Dallow N; Gilbert J; Allen A; Hall D; Nair P
    Clin Exp Allergy; 2014 Apr; 44(4):508-16. PubMed ID: 24286456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics.
    Kawayama T; Kinoshita T; Imaoka H; Gauvreau GM; O'Byrne PM; Aizawa H
    Respirology; 2008 Nov; 13(7):1000-1007. PubMed ID: 18699801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.